HYQVIA is indicated for the treatment of primary immunodeficiency (PI) in adults. HYQVIA is for subcutaneous use only. Safety and efficacy of chronic use of Recombinant Human Hyaluronidase in HYQVIA have not been established in conditions other than PI.

MyIgSource

Educational Resources for Your Patients with PI.

Support from the start.
Resources throughout their journey.

MyIgSource is designed to support your patients at diagnosis and throughout their PI journey and is open to all patients and caregivers regardless of treatment.

Your patients can visit MyIgSource to:

  • Learn more about managing their condition
  • Sign up to receive education materials that can help them and their loved ones better understand PI
  • Connect by phone or online with patient advocates that have PI or have loved ones living with the condition
  • Register for events focusing on disease education related to PI

Have your patients connect at MyIgSource.com or call 1‌-‌855‌-‌250‌-‌5111